Table 2.
Correlation of IL-2 with various inflammatory markers in non‐diabetic overweight and obese individuals.
| Inflammatory marker | Pearson Correlation | |
|---|---|---|
| r value | P-value | |
| IL-1β | 0.268 | 0.082 |
| IL-5 | − 0.105 | 0.454 |
| IL-6 | 0.01 | 0.943 |
| IL-8 | 0.481** | < 0.0001 |
| IL-10 | 0.064 | 0.642 |
| IL-12A | 0.333* | 0.029 |
| IL-13 | − 0.11 | 0.437 |
| IL-18 | 0.074 | 0.595 |
| CCL2 | − 0.069 | 0.619 |
| CCL3 | 0.135 | 0.337 |
| CCL5 | 0.677** | < 0.0001 |
| CCL8 | − 0.086 | 0.558 |
| CCL11 | 0.01 | 0.944 |
| CCL15 | − 0.167 | 0.21 |
| CCL19 | 0.538** | < 0.0001 |
| CCL20 | 0.201 | 0.133 |
| CCR1 | − 0.049 | 0.724 |
| CCR2 | 0.567** | < 0.0001 |
| CCR5 | 0.562** | < 0.0001 |
| CD16 | 0.076 | 0.577 |
| ITGAX (CD11c) | 0.324* | 0.0156 |
| CD163 | 0.261* | 0.05 |
| TNFα | 0.14 | 0.317 |
| TGFβ | 0.077 | 0.579 |
| IFNB1 | 0.052 | 0.702 |
Bold is used to highlight the significant values